Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults

INTRODUCTION: Tenofovir disoproxil fumarate (TDF) is widely recommended for treatment of chronic hepatitis B virus (HBV) infection because it is safe, affordable and has a high genetic barrier to resistance. TDF resistance associated mutations (RAMs) have been reported, but data are limited, particu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Virol
Asıl Yazarlar: Mokaya, Jolynne, Maponga, Tongai G, McNaughton, Anna L, Van Schalkwyk, Marije, Hugo, Susan, Singer, Joshua B, Sreenu, Vattipally B, Bonsall, David, de Cesare, Mariateresa, Andersson, Monique, Gabriel, Shiraaz, Taljaard, Jantje, Barnes, Eleanor, Preiser, Wolfgang, Van Rensburg, Christo, Matthews, Philippa C
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier Science 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408481/
https://ncbi.nlm.nih.gov/pubmed/32663786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2020.104548
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller